Tradename | Company | Number | Date | Products |
---|---|---|---|---|
QUESTRAN | Bristol Myers Squibb | N-016640 DISCN | 1982-01-01 | 2 products, RLD |
QUESTRAN LIGHT | Bristol Myers Squibb | N-019669 DISCN | 1988-12-05 | 2 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
cholestyramine | ANDA | 2024-08-23 |
cholestyramine for oral suspension | ANDA | 2023-01-09 |
cholestyramine light | ANDA | 2024-07-24 |
cholestyramine powder for suspension | ANDA | 2024-04-12 |
prevalite | ANDA | 2020-06-18 |
questran | ANDA | 2019-11-01 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypercholesterolemia | D006937 | HP_0003124 | — | — | 1 | 3 | 1 | 1 | 6 |
Healthy volunteers/patients | — | — | — | 1 | — | — | 2 | — | 3 |
Diarrhea | D003967 | HP_0002014 | R19.7 | — | — | — | 1 | 1 | 2 |
Malabsorption syndromes | D008286 | EFO_0009554 | K90 | — | 1 | — | 1 | — | 2 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | 1 | 1 | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 1 | 1 | — | 2 |
Diabetic neuropathies | D003929 | EFO_1000783 | — | — | — | — | 1 | — | 1 |
Diabetic retinopathy | D003930 | EFO_0003770 | — | — | — | — | 1 | — | 1 |
Ankylosing spondylitis | D013167 | EFO_0003898 | M45 | — | — | — | 1 | — | 1 |
Spondylarthritis | D025241 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperlipoproteinemia type ii | D006938 | EFO_0004911 | E78.00 | — | 1 | 3 | — | — | 4 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 1 | 3 | — | — | 4 |
Coronary disease | D003327 | — | — | — | 1 | 3 | — | — | 4 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 1 | 3 | — | — | 4 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 3 | — | — | 4 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | — | 2 | — | — | 3 |
Ischemia | D007511 | EFO_0000556 | — | — | — | 3 | — | — | 3 |
Sclerosis | D012598 | — | — | — | — | 2 | — | — | 2 |
Graves disease | D006111 | EFO_0004237 | E05.0 | — | — | 1 | — | 1 | 2 |
Hyperthyroidism | D006980 | — | E05.9 | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | 1 | — | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 1 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | — | — | — | 1 |
Fatty liver | D005234 | EFO_0003934 | — | — | 1 | — | — | — | 1 |
Short bowel syndrome | D012778 | — | K90.82 | — | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | — | 1 | — | — | — | 1 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | — | 1 |
Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | — | 1 |
Smoldering multiple myeloma | D000075122 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | D000230 | — | — | 1 | — | — | — | 1 | 2 |
Microbiota | D064307 | — | — | 1 | — | — | — | — | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Biliary liver cirrhosis | D008105 | — | K74.3 | 1 | — | — | — | — | 1 |
Cholestasis | D002779 | HP_0001396 | K83.1 | 1 | — | — | — | — | 1 |
Intrahepatic cholestasis | D002780 | — | — | 1 | — | — | — | — | 1 |
Alagille syndrome | D016738 | EFO_0004151 | Q44.71 | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colonic neoplasms | D003110 | — | C18 | — | — | — | — | 1 | 1 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | — | — | — | 1 | 1 |
Hyperlipoproteinemias | D006951 | HP_0010980 | — | — | — | — | — | 1 | 1 |
Carotid stenosis | D016893 | — | — | — | — | — | — | 1 | 1 |
Carotid endarterectomy | D016894 | — | — | — | — | — | — | 1 | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
Bariatric surgery | D050110 | — | — | — | — | — | — | 1 | 1 |
Abdominal obesity | D056128 | HP_0001956 | — | — | — | — | — | 1 | 1 |
Drug common name | Cholestyramine |
INN | colestyramine |
Description | Colestyramine (INN) or cholestyramine (USAN) (trade names Questran, Questran Light, Cholybar, Olestyr) is a bile acid sequestrant, which binds bile in the gastrointestinal tract to prevent its reabsorption. It is a strong ion exchange resin, which means it can exchange its chloride anions with anionic bile acids in the gastrointestinal tract and bind them strongly in the resin matrix. The functional group of the anion exchange resin is a quaternary ammonium group attached to an inert styrene-divinylbenzene copolymer.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 11041-12-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1201625 |
ChEBI ID | — |
PubChem CID | 70695640 |
DrugBank | DB01432 |
UNII ID | 4B33BGI082 (ChemIDplus, GSRS) |